IGC IGC Pharma, Inc.

AMEX
$0.30

IGC Pharma, Inc. (IGC) is expected to report earnings on November 13, 2026, before the market open. The consensus earnings estimate is a loss of $0.02 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -0.4% since its last earnings release on August 14, 2026.

IGC Pharma Missed Consensus Estimates
Earnings Date
3rd Quarter, Sep 2026
Nov 13
Friday · Before Open
Earnings Whisper
-
vs ($0.02)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.28

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About IGC Pharma, Inc.

India Globalization Capital Inc is engaged in acquiring, incubating, financing and growing companies in multiple industries & locations. The Company trades iron ore & lease construction equipment in India; and operates iron ore plants in China.

Sector

Healthcare

Industry

Drug Manufacturers/Other